FDA NEWS

Sector Snap: Diabetes drug developers - MSN MoneyCentral
Amylin Ord Shs ( AMLN ) Stock Quote , Chart , News , Add to Watchlist NEW YORK (AP) - Proposals for tougher heart-risk studies on new Type 2 diabetes drugs weighed heavy on shares of Amylin Pharmaceuticals Inc. and Novo Nordisk AS Thursday, since
Source: news.moneycentral.msn.com

Wyeth, Progenics bowel drug wins EU approval - Guardian Unlimited
NEW YORK, July 3 (Reuters) - Wyeth and Progenics Pharmaceuticals Inc won European approval for Relistor, a drug used to treat constipation that occurs with the use of opioid painkillers, like morphine, the companies said on Thursday. The drug will be
Source: www.guardian.co.uk

Wyeth, Progenics get European constipation drug OK - Forbes
Drug developers Wyeth and Progenics Pharmaceuticals Inc. said Thursday European regulators approved Relistor as a treatment for constipation related to pain drugs taken by terminally ill patients. The injectable drug relieves opioid-induced
Source: www.forbes.com